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The Main Characteristics of Interpersonal Psycho-
therapy for Major Depression
Interpersonal model of psychotherapy integrates both the relational 
theory of Harry Stack Sullivan [1] and the attachment theory of John 
Bowlby [2]. Sullivan asserted that “a person can never be isolated from the 
complex of interpersonal relations in which the person lives and has his 
being”. This idea was influenced by the integrative psychobiological theories 
of Adolf Meyer [3] and based on the clinical observation of a primary social 
group and the immediate involvement of the subject with one or more 
significant persons. Individual personality is defined by the relations that 
are established and by the social role that the he plays. According to John 
Bowlby’s attachment theory, secure attachment to the caregiver early in 
life forms the foundation for later success in interpersonal relationships. 
Interpersonal therapy was designed on the basis of these theories and is 
focused on the patient’s intimate relationships.
Interpersonal psychotherapy (IPT) was proposed in 1984 by 
Klerman and colleagues [4], who defined the methods and techniques 
of this psychotherapeutic approach for patients with a diagnosis of 
major depression. Traditional IPT is a time-limited, diagnosis-focused, 
life-event-based treatment consisting of 12-16 weekly sessions. The 
intervention has a distinct medical setting based on the formulation and 
communication of a diagnosis, and on the transitory attribution of the 
phenomena of illness to the patient. During IPT sessions the intervention 
is focused on one of four interpersonal problem areas that patient and 
therapist together identify and choose: grief, interpersonal role disputes, 
role transitions, and interpersonal deficits. Interpersonal approach 
removes responsibility from the patient regarding guilt and frustration for 
their emotional experience and at the same time defines the symptoms in 
a syndromic context that is known and therefore curable. 
Adaptation of IPT to Other Psychiatric Disorders: The 
Case of Borderline Personality Disorder 
The efficacy of IPT in treatment of major depression is well-
established, and recent meta-analyses have confirmed its efficacy in 
both monotherapy and in association with pharmacotherapy [5,6]. The 
promising results that this psychotherapeutic intervention has obtained 
in its primary indication, unipolar major depression, have led clinicians 
and investigators to enlarge the application of IPT beyond this clinical 
population. So, IPT has been studied in several psychiatric disorders: 
dysthymia [7-10], bipolar disorder [11-15], substance abuse [16-18], 
post-traumatic stress disorder [19]; social phobia [20], panic disorder 
[21-23], and eating disorders [24-27]. However, specific adaptations 
of the traditional model of IPT have been required for each disorder 
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considering the different clinical characteristics of these disturbances 
and the peculiar needs of patients.
Among personality disorders, IPT has been used in patients with 
borderline personality disorder (BPD) that is a heterogeneous and 
severe mental disorder, characterized by dysregulation in interpersonal 
relationships, affects and emotions, sense of self, and control of 
impulsivity. Its prevalence is approximately ranged between 1 and 5% 
in general population, up to 25-30% in psychiatric outpatients [28-30]. 
Subjects with BPD, because of their pervasive instability, often show 
a scarce compliance to both pharmacological and psychotherapeutic 
interventions. So, it is a great challenge for the clinician to establish a 
solid therapeutic alliance based on the mutual cooperation with these 
patients. Most of BPD patients, due to a marked intolerance to stress 
and frustrations and poor identity cohesion, cannot tolerate long-
term psychotherapies that adopt explorative techniques and strict 
boundaries of setting. Moreover, patients with BPD often develop a 
relational dependency with fear of abandonment that may be elicited 
by too long-lasting treatment modalities. On the other hand, time-
limited interventions can be too short to obtain a significant change 
in the main psychopathological dimensions. The risk of self-mutilating 
behaviours and suicide is another element that must be considered in 
the treatment approach of this clinical population. A more containing 
and comforting therapeutic approach and the opportunity to contact 
therapist during the crises outside the sessions may prevent acting out 
and self-damaging conducts. While on one hand BPD patients require 
a major setting flexibility, on the other hand well defined boundaries of 
the therapeutic interventions should be explicated to the subjects at the 
beginning of the therapy to stem their manipulative attitudes. 
The frequent comorbidity of BPD with mood disorders and the 
relational problems due to borderline core symptoms are the main 
reasons for the proposal of IPT for BPD patients.
In the light of all this factors, the traditional model of IPT might 
not address the complexity and heterogeneity of BPD psychopathology 
and a specific adaptation was required to deal with the peculiar 
characteristics of these patients. 
Initial Studies of Efficacy of IPT in BPD
The first attempt to adapt the traditional model of IPT to BPD 
psychopathology was performed by Angus and Gillies in 1994 [31]. 
They maintained the brief duration of 12 weeks and the intensive format 
of the traditional IPT, but added fifth problematic areas: the image of 
self. Authors considered the interpersonal relational dysfunction of 
BPD patients in the context of their labile sense of self and conducted 
a pilot randomized controlled trial in 24 patients who were assigned to 
IPT or Relational Management Therapy. Unfortunately, the study was 
early concluded because of the high rate of drop-outs (75%).
The standard model of IPT for major depression was subsequently 
modified by Markowitz [32] adapting the intervention to deal with 
difficulties in interpersonal relationships, chronicity of BPD, poor 
therapeutic alliance, and the high risk of suicide and self-harm of these 
patients. In particular, the features of the adaptation involved a different 
conceptualization of the disorder, prolonged length of treatment, and 
a more flexible setting. Markowitz and colleagues conceptualized BPD 
as a “mood-inflected chronic illness, but punctuated by sporadic and 
ineffective outbursts of anger and impulsivity”. The duration of IPT was 
extended to thirty-six 50-minute sessions over 32 weeks, divided into 
two stages, both of 16 weeks. The aims of the initial phase were to create 
a valid therapeutic alliance, to limit self-mutilating acts, and to provide 
an initial symptoms relief. If patients successfully completed this phase, 
they entered the continuation phase, in which the therapeutic alliance 
was reinforced, initial gains were increased, more adaptive interpersonal 
mechanisms were developed, and the termination of therapy was 
discussed. In addition, IPT adapted to BPD (IPT-BPD) allowed patients 
to contact therapist with one 10-minute telephone call once weekly, if 
necessary, in order to contain crises and maintain a strong alliance. 
Clinical efficacy of this model of IPT specifically adapted to suit the 
needs of BPD patients was investigated with clinical trials during the 
last decade. The first pilot study was performed by Markowitz [32] on 
8 BPD patients with comorbid mood disorders and other personality 
disorders that were treated for 8 months with IPT-BPD. Five patients 
completed the study showing a significant improvement at the Clinical 
Global Impression Scale (CGI), the Hamilton Depression Rating 
Scale (HDRS), the Self-Rating Anxiety Scale (SAS), and the Symptom 
Checklist-90 (SCL-90). Moreover, no patient fulfilled diagnostic criteria 
of BPD at the end of the trial.
Controlled Trials of IPT-BPD: Efficacy, Follow-Up and 
Predictors of Response
Since 2010, our research group at the University of Turin, Italy, 
conducted three randomized controlled trial to investigate whether the 
adapted model of IPT may impact on the core BPD psychopathology.
According to clinical data and APA guidelines [33,34] treatment 
options for BPD include both pharmacotherapy and psychotherapy. 
Combination of a specific psychotherapy for BPD with drugs, for example 
a selective serotonergic antidepressant, is common in clinical practice 
and is recommended in guidelines as first choice in treating affective 
dysregulation and impulsive behavioral dyscontrol of BPD. Moreover, 
there is some evidence that psychotherapy may enhance the effects of 
pharmacotherapy [35,36]. For these reasons and in order to better handle 
the heterogeneity and the severity of clinical manifestations of BPD, in 
our trials we retained appropriate to treat all patients with a medication, 
used as single therapy or associated with psychotherapy. Fluoxetine was 
chosen because it has been studied in several controlled trials [37-40] and 
is recommended by APA treatment guidelines.
In the first trial [41], aimed to compare the efficacy of the 
combined treatment with IPT-BPD plus pharmacotherapy versus single 
pharmacotherapy, we enrolled 55 BPD patients without other concomitant 
psychiatric disorders. Participants were randomly assigned to two types of 
treatments: fluoxetine at a dose from 20 to 40 mg/day (27 patients) plus 
IPT-BPD versus fluoxetine at the same dose plus clinical management (a 
visit lasting 15-20 minutes every 2 weeks focused on clinical issues) (28 
patients) for a period of 32 weeks. Forty-four patients completed the study, 
22 in each group. The primary outcomes were score changes of Clinical 
Global Impression-Severity (CGI-S), Borderline Personality Disorder 
Severity Index (BPDSI) and BPDSI single items. Secondary outcomes 
were score changes of Hamilton Anxiety Rating Scale (HARS), Hamilton 
Depression Rating Scale (HDRS), Social and Occupational Functioning 
Assessment Scale (SOFAS), and Satisfaction Profile (SAT-P). Results 
showed that, after 8 months, the two treatment options did not obtain 
different effects on general symptoms and total BPD symptoms. Moreover, 
both treatments had the same efficacy on depressive symptoms and 
social and occupational functioning. Combined therapy with IPT-BPD 
was superior to single drug therapy in reducing anxious symptoms and 
improving subjective perception of quality of life in terms of two factors: 
psychological and social functioning. A significant difference in favor of 
combined therapy was found for three BPD symptom clusters: disturbed 
interpersonal relationships, inadequate control of impulsive behaviors and 
affective instability.
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As BPD is a chronic and lifelong disorder, one of the most important 
criteria for evaluating the efficacy of treatment is the long-term outcome. 
The second of our studies [42] was aimed to verify whether the benefits 
from the addition of interpersonal psychotherapy to pharmacotherapy 
after 32 weeks of treatment persisted during a follow-up period of two years 
after termination of psychotherapy. Forty-four patients who completed the 
32 weeks trial (22 who received combined therapy and 22 who received 
single fluoxetine) underwent 24 months of follow-up. All subjects received 
single pharmacotherapy with fluoxetine (20-40 mg/day) during the 
follow-up period. Thirty patients concluded the follow-up. The primary 
and secondary outcomes were the same indicated for the 32 weeks trial of 
efficacy. Findings suggested that a psychotherapy specifically adapted for 
BPD patients had positive effects that endured for a long period after its 
termination. A large part of the differences between combined therapy and 
single pharmacotherapy registered in BPD patients at the end of a 32 weeks 
trial were maintained after 24 months of follow-up. 
In particular, the addition of IPT-BPD to fluoxetine produced 
greater effects on impulsive behavioral dyscontrol and interpersonal 
relationships instability that were significantly maintained during the 24 
months follow-up period, as measured with the two items “impulsivity” 
and “interpersonal relationships” of the BPDSI. Moreover, BPD patients 
experienced a long-lasting improvement of two key factors of quality of 
life, subjective perception of psychological and social functioning, as 
assessed with the SAT-P. On the contrary, the advantage of combined 
therapy in terms of improvement of anxiety and affective instability was 
not replicated at follow-up.
As indicated by these results, the combined therapy with IPT adapted 
to BPD is a promising time-limited treatment option, able to obtain 
effects superior to single pharmacotherapy on a few core symptoms 
of BPD and on subjective quality of life. The most of these effects are 
still significantly superior to control group after a long-term follow-up. 
This kind of intervention requires a consistent investment of clinical 
resources, cannot be guaranteed to all patients, and should be provided 
to patients selected on the basis of predictive factors of response. We 
performed a further analysis of our data [43] in order to identify 
which demographic and clinical factors were predictors of response 
to combined treatment with IPT-BPD and fluoxetine. We considered 
the 27 patients allocated to combined therapy in our clinical trial (41). 
Clinical response was measured by the change of CGI-S score between 
baseline and week 32. Findings indicated that patients with more severe 
global BPD symptoms (assessed with the BPDSI total score) and with 
higher level of fear of abandonment, affective instability, and impaired 
identity (measured with the three BPDSI items “abandonment”, “affective 
instability”, and “identity”) presented a significantly better response to 
combined therapy with IPT-BPD and fluoxetine. The most important 
implication of this study is that the clinical improvement of patients 
seemed not dependent from the baseline severity of general symptoms, 
but was more specifically related to the core BPD psychopathology. This 
finding is in accordance with previous investigations [44-46], indicating 
that higher pre-treatment severity of BPD predicted greater symptom 
change with different models of psychotherapies (IPP-Integrative 
Psychotherapy Practice, Schema- focused therapy, Transference-focused 
psychotherapy, and STEPPS).
Characteristics and results of the three trials are presented in Table 1.
Authors Treatment Sample Duration Significant outcomes P ≤ 0.05 Non significant outcomes
Bellino et al., 
2010
fluoxetine (20-40 mg/day) 
+IPT-BPD versus fluoxetine 
(20-40 mg/day) +CM
55 BPD patients
11 drop outs
32 weeks
fluoxetine+IPT-BPD>fluoxetine+CM on: 
HARS; 
BPDSI items: 
affective instability, impulsivity,
interpersonal relationships;
SAT-P factors:
psychological functioning, social functioning
HDRS;
CGI-S;
SOFAS;
BPDSI total score and items:
abandonment,
identity;
outbursts of anger,
dissociation/paranoid ideation, 
emptiness,
parasuicidal behaviors
Bellino et al.,
in press fluoxetine 20-40 mg/day
44 BPD patients 
who completed 
the 32 weeks 
trial
14 drop outs
follow-up 24 
months
fluoxetine+IPT-BPD>fluoxetine+CM on: 
BPDSI items: 
impulsivity,
interpersonal relationships;
SAT-P factors:
psychological functioning, social functioning
HARS;
HDRS;
CGI-S;
SOFAS;
BPDSI total score and items:
affective instability,
abandonment,
identity,
outbursts of anger,
dissociation/paranoid ideation,
emptiness,
parasuicidal behaviors
Bellino et al.,
2015
fluoxetine (20-40 mg/day) 
+IPT-BPD
27 BPD patients
5 drop outs 32 weeks
predictive factors:
BPDSI total score and items:
abandonment,
identity,
affective instability
non-predictive factors:
CGI-S;
HARS;
HDRS;
SOFAS;
SAT-P;
BPDSI items:
interpersonal relationships,
impulsivity,
outbursts of anger,
parasuicidal behaviors,
dissociation/paranoid ideation,
emptiness
Table 1: Results of three RCTs investigating treatment efficacy, outcome of follow-up, and predictors of response of combined therapy with IPT-BPD and fluoxetine 
compared with single fluoxetine. IPT-BPD: Interpersonal Psychotherapy adapted to Borderline Personality Disorder; CM: Clinical Management; BPD: borderline personality 
disorder; CGI-S: Clinical Global Impression-Severity Item; SOFAS: Social and Occupational Functioning Assessment Scale; HARS: Hamilton Anxiety Rating Scale; HDRS: 
Hamilton Depression Rating Scale; BPDSI: Borderline Personality Disorder Severity Index; SAT-P: Satisfaction Profile.
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A Proposal of Revision of IPT-BPD
In the last years, we designed a proposal of revision (IPT-BPD-R) of 
Markowitz’s adaptation of IPT to BPD in the attempt to overcome some 
limitations of this model that emerged during clinical practice. In our 
opinion, 32 weeks of treatment are still rather few and often insufficient 
to obtain a long-lasting psychopathological improvement. So, our 
proposal is to prolong treatment duration up to 10 months of therapy 
divided into two phases of 22 sessions (20 weeks) and 20 sessions (20 
weeks). As the conclusion of psychotherapy is particularly problematic 
to accept for BPD subjects, three additional sessions can be provided if 
patients present serious difficulties during the termination phase.
In selected patients, for example those who suffer from severe baseline 
BPD psychopathology, higher levels of impulsive and self-mutilating 
behaviors, higher risk of suicide, and severe identity disturbance, a 
maintenance therapy of 8 monthly sessions is administered. Two weekly 
contacts by phone with the therapist are allowed in situations of crisis, 
as well as two admissions to hospital for a brief period of 7-10 days. 
During the hospitalisation IPT-BPD-R continues if the patient’s clinical 
conditions allow it. In our revised model of IPT-BPD is also included an 
intervention for family members of patients aimed to decrease the level 
of perceived stress and to help them to better understand the illness of 
their relative. The intervention consists of six monthly 1-hour sessions 
of interpersonal counselling (IPC) that can be provided to one or two 
cohabiting family members. During the first session family members 
receive psychoeducation about BPD. In the middle sessions therapist 
and family members together choose the focus of IPC (among the 
four interpersonal problematic areas of traditional IPT), analyse the 
dysfunctional modalities of interpersonal relationships and promote 
new interpersonal skills. In the last session conclusion of IPC and 
obtained results are discussed.
These changes to the initial adaptation of IPT to BPD patients are 
required in our opinion on the basis of several considerations:
1) the need to provide BPD patients a more supportive intervention, 
in order to deal with low level of compliance and high risk of impulsive 
conducts;
2) the advantage of designing a more flexible model of 
psychotherapy, that can provide more tailored treatments for complex 
and heterogeneous clinical picture;
3) a longer duration is preferable in order to provide a comparable 
length of treatment with other models of psychotherapy for BPD, such 
as mentalization based therapy [47] and dialectical behaviour therapy 
[48];
4) the considerable differences of BPD patients to acquire more 
adaptive patterns of interpersonal relationships is a further reason to 
increase the number of sessions and to provide a continuation phase 
in selected cases;
5) Psychoeducation and counselling of family members of BPD 
patients can produce important effects on relationships between 
the patient and his relatives/caregivers and secondarily improve his 
symptoms and functions.
The revised model of IPT for borderline personality disorder is 
currently administered to our BPD outpatients and will be the focus of 
a clinical controlled trial of efficacy.
In conclusion, combined treatment with IPT adapted to BPD 
and antidepressant medications can be considered a useful treatment 
option. The efficacy of this combined therapy was superior to single 
pharmacotherapy in improving some core BPD symptom clusters. 
The main effects of IPT-BPD registered after 32 weeks of treatment 
were maintained during a follow-up period of two years. More severe 
BPD symptoms and higher degree of fear of abandonment, affective 
instability, and impaired identity were predictors of response to 
combined therapy with IPT-BPD. More trials are required to replicate 
these initial findings. In fact, our studies suffer from some limitations: 
the sample size is limited; exclusion of psychiatric comorbidity may 
imply that our population has different clinical characteristics from 
patients of clinical practice; reliable assessment of effects of IPT 
combination requires more specific instruments; intention-to-treat 
analysis was not performed.
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